Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
39.20
-0.25 (-0.63%)
May 8, 2026, 1:58 PM CST

TPEX:7427 Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-97.47-104.92-61-67.13-35.86
Depreciation & Amortization
7.686.94.281.761.44
Other Amortization
-0.040.070.060.06
Loss (Gain) From Sale of Assets
---0.12--
Stock-Based Compensation
11.1614.9711.294.913.66
Other Operating Activities
0.10.130.09-0.01-0.03
Change in Accounts Receivable
0.65-0.62-0.09--0.04
Change in Inventory
-4.283.15-6.16--
Change in Accounts Payable
-2.956.611.05--
Change in Other Net Operating Assets
-2.44-3.09-4.4-16.76-3.15
Operating Cash Flow
-87.56-76.85-54.99-77.17-33.92
Capital Expenditures
-0.28-2.11-2.93-0.05-0.04
Sale of Property, Plant & Equipment
--0.12--
Sale (Purchase) of Intangibles
-3.21-1.36-16.29-1.18-27.97
Investment in Securities
10-130.7-160.5-74.19-62.32
Other Investing Activities
2.860.68-3.18-2.45-
Investing Cash Flow
9.37-133.49-182.78-77.85-90.32
Long-Term Debt Repaid
-3-3-1.25--
Net Debt Issued (Repaid)
-3-3-1.25--
Issuance of Common Stock
0.94188.84307.49203.31120
Repurchase of Common Stock
-44.97----
Financing Cash Flow
-47.03185.84306.24203.31120
Net Cash Flow
-125.22-24.4968.4748.29-4.24
Free Cash Flow
-87.84-78.96-57.92-77.21-33.96
Free Cash Flow Margin
-7289.46%-4685.82%-1194.21%-14298.70%-5389.68%
Free Cash Flow Per Share
-2.04-1.92-1.60-3.20-1.61
Levered Free Cash Flow
-63.66-53.21-48.79-50.61-29.53
Unlevered Free Cash Flow
-63.6-53.14-48.73-50.61-29.53
Change in Working Capital
-9.036.04-9.6-16.76-3.19
Source: S&P Global Market Intelligence. Standard template. Financial Sources.